Ipilimumab vs Mezlocillin Sodium
Ipilimumab vs Mezlocillin Sodium: Overview
This comparison examines the pharmacological differences between Ipilimumab and Mezlocillin Sodium.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days.
Chemical Properties
Type: Ipilimumab β Antibody; Mezlocillin Sodium β Small molecule.